Ocular Therapeutix Inc
OCUL
Market Cap$971.15M
Close$
$10.44
69.2% upside
Current Fair Value
69.2% upsideUndervalued by 69.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $971.15 Million |
|---|---|
| Enterprise Value | $562.67 Million |
| Dividend Yield | $0.0 (0.0%) |
| Earnings per Share | $-1.16 |
| Beta | 1.98 |
| Outstanding Shares | 154,888,915 |
| Avg 30 Day Volume | 3,682,496 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -8.43 |
|---|---|
| PEG | -7.4 |
| Price to Sales | - |
| Price to Book Ratio | 3.09 |
| Enterprise Value to Revenue | 9.4 |
| Enterprise Value to EBIT | -6.15 |
| Enterprise Value to Net Income | -5 |
| Total Debt to Enterprise | 0.13 |
| Debt to Equity | 0.18 |
Revenue Sources
No data
ESG Score
No data
About Ocular Therapeutix Inc
CEO: Antony Mattessich